您的位置: 首页 > 农业专利 > 详情页

Benzimidazole derivatives and their use against Proline; orexinergicas Dysfunctions.
专利权人:
ACTELION PHARMACEUTICALS LTD.;IDORSIA PHARMACEUTICALS LTD.
发明人:
GUDE MARKUS,BOSS CHRISTOPH,BROTSCHI CHRISTINE,HEIDMANN BIBIA,SIFFERLEN THIERRY,WILLIAMS JOSI T.
申请号:
CL2014003294
公开号:
CL2014003294A1
申请日:
2014.12.02
申请国别(地区):
CL
年份:
2015
代理人:
摘要:
The present invention relates to compounds of the formula (I) wherein Ar1, R1, R2, R3, R4a, R4b and (R5)n are as described in the description, to their preparation, to pharmaceutically acceptable salts thereof, and to their use as pharmaceuticals, to pharmaceutical compositions containing one or more compounds of formula (I), and especially to their use as orexin receptor antagonists.COMPUESTOS DERIVADOS DE BENCIMIDAZOL-PROLINA, ANTAGONISTA DEL RECEPTOR DE OREXINA; COMPOSICIÓN FARMACÉUTICA QUE LOS COMPRENDE; Y SU USO EN EL TRATAMIENTO DE ENFERMEDADES O TRASTORNOS SELECCIONADOS ENTRE SUEÑO, ANSIEDAD, COGNITIVAS, APETITO, ENTRE OTRAS.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充